HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert J Fox Selected Research

Robert J Fox Research Topics

Disease

70Multiple Sclerosis
06/2022 - 08/2002
29Relapsing-Remitting Multiple Sclerosis
01/2022 - 02/2008
12Atrophy
01/2022 - 04/2005
9Chronic Progressive Multiple Sclerosis
09/2022 - 06/2004
6Inflammation (Inflammations)
01/2022 - 06/2006
6Disease Progression
11/2021 - 05/2007
4Progressive Multifocal Leukoencephalopathy
12/2021 - 06/2013
4Flushing
03/2017 - 09/2012
3COVID-19
04/2022 - 01/2021
3Diarrhea
01/2022 - 05/2016
3Neuromyelitis Optica (Devic's Disease)
01/2021 - 11/2008
3Demyelinating Diseases (Demyelinating Disease)
05/2013 - 05/2007
2Nausea
01/2022 - 03/2017
2Ganglion Cysts (Ganglion)
03/2021 - 01/2021
2Abdominal Pain (Pain, Abdominal)
03/2017 - 05/2016
2Psoriasis (Pustulosis Palmaris et Plantaris)
01/2016 - 02/2013
1Exanthema (Rash)
01/2022
1Infections
01/2022
1Clinical Deterioration
01/2022
1Fatigue
01/2021
1Non-alcoholic Fatty Liver Disease
01/2021
1Hypertension (High Blood Pressure)
01/2018
1Headache (Headaches)
01/2018
1Herpes Zoster
01/2018
1Chickenpox
01/2018
1Lymphopenia (Lymphocytopenia)
01/2018
1Bradycardia
01/2018
1Sclerosis
08/2017
1Vomiting
03/2017
1Neoplasms (Cancer)
01/2016
1Acquired Immunodeficiency Syndrome (AIDS)
01/2016
1Crohn Disease (Crohn's Disease)
06/2013

Drug/Important Bio-Agent (IBA)

35Dimethyl FumarateIBA
01/2022 - 09/2012
11Natalizumab (Tysabri)FDA Link
12/2021 - 02/2012
9siponimodIBA
09/2022 - 06/2015
9ibudilastIBA
11/2021 - 06/2015
6Glatiramer Acetate (Copaxone)FDA Link
11/2021 - 09/2012
5Rituximab (Mabthera)FDA Link
11/2021 - 02/2008
5Biomarkers (Surrogate Marker)IBA
11/2021 - 01/2006
5Fingolimod Hydrochloride (FTY720)FDA Link
12/2019 - 11/2016
4InterferonsIBA
11/2021 - 11/2005
3ocrelizumabIBA
11/2021 - 06/2015
3hydroxide ionIBA
03/2021 - 10/2018
3Retinaldehyde (Retinal)IBA
03/2021 - 01/2016
3GadoliniumIBA
01/2021 - 11/2010
3Chemokine ReceptorsIBA
01/2009 - 01/2006
2Vitamin DFDA LinkGeneric
03/2021 - 10/2019
2Pharmaceutical PreparationsIBA
01/2016 - 06/2004
2SteroidsIBA
11/2015 - 05/2007
2AntibodiesIBA
07/2014 - 12/2006
2Adrenal Cortex Hormones (Corticosteroids)IBA
12/2006 - 04/2005
2Mitoxantrone (Novantrone)FDA LinkGeneric
06/2006 - 06/2004
1Sphingosine-1-Phosphate ReceptorsIBA
09/2022
1Influenza Vaccines (Influenza Vaccine)FDA Link
04/2022
1COVID-19 VaccinesIBA
04/2022
1CalciumIBA
01/2022
1Cytidine Diphosphate (CDP)IBA
01/2022
1Tyrosine Kinase InhibitorsIBA
01/2022
1Dihydroorotate DehydrogenaseIBA
01/2022
1vidofludimusIBA
01/2022
1masitinibIBA
01/2022
1W 12IBA
01/2022
1IronIBA
12/2021
1CladribineFDA LinkGeneric
11/2021
1Alemtuzumab (Campath)FDA Link
11/2021
1EnzymesIBA
01/2021
1Myelin-Oligodendrocyte GlycoproteinIBA
01/2021
1teriflunomideIBA
01/2021
1ponesimodIBA
01/2021
1Agammaglobulinaemia Tyrosine KinaseIBA
01/2021
1Protons (Proton)IBA
01/2021
1Monoclonal AntibodiesIBA
01/2020
125-hydroxyvitamin DIBA
10/2019
1Calcifediol (Calcidiol)FDA Link
10/2019
1Myelin ProteinsIBA
10/2018
1Macrophage Migration-Inhibitory FactorsIBA
01/2018
1Cyclic NucleotidesIBA
01/2018
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2018
1Transaminases (Aminotransferases)IBA
01/2018
1Toll-Like Receptor 4IBA
01/2018
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2017
1Neuroprotective AgentsIBA
06/2016
1Interferon-betaIBA
05/2016
1efalizumab (Raptiva)FDA Link
01/2016
1IntegrinsIBA
01/2016
1Phosphodiesterase InhibitorsIBA
06/2015
1Simvastatin (Zocor)FDA LinkGeneric
06/2015
1N-acetyltalosaminuronic acid (NAT)IBA
05/2015
1FumaratesIBA
03/2015
1AMPA Receptors (AMPA Receptor)IBA
05/2013
1MicroRNAs (MicroRNA)IBA
05/2013

Therapy/Procedure

34Therapeutics
06/2022 - 08/2002
2Assisted Suicide (Physician Assisted Suicide)
04/2017 - 01/2017
1Activities of Daily Living (ADL)
01/2021
1Precision Medicine
01/2018
1Mesenchymal Stem Cell Transplantation
01/2018
1Immunomodulation
01/2016
1Cell- and Tissue-Based Therapy (Cell Therapy)
06/2015
1Complementary Therapies (Alternative Medicine)
03/2014
1Injections
01/2013